CTLA-4 checkpoint inhibitor (Euchloe Bio)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameCTLA-4 checkpoint inhibitor (Euchloe Bio)

Drug Alias NameCTLA-4 targeting antibody (Euchloe Bio)cytotoxic T-lymphocyte-associated protein-4 targeting antibody (Euchloe Bio)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors

TargetsCytotoxic T-Lymphocyte-Associated Antigen 4

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySingapore

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEuchloe Bio Pte Ltd

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A